PSCHvsBBCETF Comparison
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. Virtus LifeSci Biotech Clinical Trials ETF (BBC) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.65% for BBC. PSCH is up 20.24% year-to-date (YTD) with -$10M in YTD flows. BBC performs better with 28.33% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of PSCH and BBC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PSCH vs BBC performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH BBC | +5.27%+1.30% | +19.02%+7.83% | +20.24%+28.33% | +36.79%+127.45% | +19.78%+114.85% | -15.14%+13.01% |
| Flows | PSCH BBC | +$6M+$83K | +$9M+$7M | -$10M+$5M | -$13M+$11M | -$133M+$15M | -$230M+$6M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH BBC | +17.29%+38.55% | +20.07%+35.78% | +21.86%+37.03% | +22.90%+39.66% |
| Max drawdown | PSCH BBC | -2.96%-11.64% | -15.36%-14.64% | -22.80%-54.25% | -46.32%-70.93% |
| Max drawdown duration | PSCH BBC | 17d54d | 168d60d | 488d340d | 1786d1754d |
PSCH | BBC | |
Last sale 7/27/2026 at 5:11 PM | $53.16 | $50.44 |
| Previous close 07/24/2026 | $52.95 | $49.67 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PSCH | BBC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PSCH | BBC | |
|---|---|---|
| Last price | $53.16 | $50.44 |
| 1D performance | +0.40% | +1.56% |
| AuM | $162.74 M | $47.16 M |
| E/R | 0.29% | 0.65% |
PSCH | BBC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | LifeSci Biotechnology Clinical Trials Index |
| N° of holdings | 75 | 125 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | December 16, 2014 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
